Dr. Yvonne Greenstreet has been appointed senior vice president and head of medicines development for Pfizer’s Specialty Care Business Unit. Dr. Greenstreet will assume global responsibility for leading the advancement of the development portfolio and ensuring its alignment with Specialty Care’s strategic objectives. Dr. Greenstreet replaces Dr. Michael Berelowitz, who is retiring from the company. She will report directly to Mr. Germano. “Yvonne has a strong track record of leadership and ou...